Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window The FDA approved the first generics of the direct oral ...
At three months of follow-up, patients hospitalized for a serious heart attack who were treated with the oral blood thinner rivaroxaban for a blood clot in the left ventricle did as well as ...
†Half of renally-cleared rivaroxaban is cleared as unchanged drug and half as inactive metabolites. ‡Potent inhibitors of both CYP3A4 and P-gp include azole antifungals (e.g., ketoconazole ...
CHICAGO, IL—Patients who develop thrombus in the left ventricle following myocardial infarction fare equally well when treated with rivaroxaban (Xarelto; Bayer/Janssen) as they do with warfarin, the ...
Medpage Today on MSN1mon
First Generics for Low-Dose Rivaroxaban Get FDA ApprovalThe FDA approved the first generics of the direct oral anticoagulant rivaroxaban, the agency announced on Tuesday.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback